Compare Ecopetrol SA (EC) vs Medpace Holdings Inc (MEDP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ecopetrol SA vs Medpace Holdings Inc — how do they compare? Ecopetrol SA trades at $16.92 (market cap $33.69B), while Medpace Holdings Inc trades at $600.79 (market cap $16.90B). The key difference: Ecopetrol SA is the larger of the two by market cap, and Ecopetrol SA pays a 3.82% dividend while Medpace Holdings Inc pays none. Which is the better fit depends on your goals.
| EC | MEDP | |
|---|---|---|
Market Cap | $33.69B | $16.90B |
Sector | Energy | Technology |
52-Week High | $17.40 | $620.59 |
52-Week Low | $8.56 | $393.42 |
Enterprise Value | $63.86B | $16.52B |
Dividend Yield | 3.82% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Ecopetrol (EC) trades at $16.93, down 0.7% on the day, with a mixed technical picture showing a bullish moving average signal but neutral oscillators. Fundamentally, the company reported a Q2 2026 EPS beat ($0.858 actual vs. $0.79 expected) but faces declining revenue and net income trends. Recent news includes a cybersecurity incident in July 2026 and the acquisition of a stake in Brava Energia in August 2026.
The outlook is cautious. While valuation ratios appear reasonable (P/E of 11.11, P/S of 0.97), declining profitability and a mixed analyst consensus (27% Buy, 55% Hold) suggest limited near-term upside. Key risks include operational pressures from falling revenue, high debt levels, and the financial impact of the recent cyberattack.
MEDP trades at $600.00, down 0.4% on the day, with a bullish technical signal driven by moving averages. The company reported strong Q2 2026 earnings, beating estimates with EPS of $4.25, and raised full-year guidance. Revenue growth is robust, with 2026 projected at $2.8 billion, though valuation multiples like a P/E of 35.58 and P/B of 38.95 are elevated. Net cash flow is expected to turn positive in 2026, and institutional activity is mixed, with some funds increasing stakes while others trim positions.
Outlook is positive due to earnings momentum and record bookings, but risks include high valuation sensitivity and a shareholder lawsuit investigation. Analyst consensus is a $599.57 price target with a 'Hold' bias, suggesting limited near-term upside from current levels amid growth-priced expectations.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Ecopetrol SA
Ecopetrol SA is a vertically integrated oil company with operations in Latin America and the United States Gulf Coast. Based out of Colombia, the company explores, develops, and conducts production activities in various countries. Ecopetrol works as the primary operator or partner in a joint venture, in a host of assets held onshore and offshore. Along with production, the company refines and markets crude oils and byproducts produced from its fields. Crude products are moved by Ecopetrol through a series of pipelines throughout Colombia, along with a network of third-party production centers and facilities.
Read more on EC →About Medpace Holdings Inc
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →
